Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Identify a reliable starting point by focusing on liquidity, security, and real-world use cases that resonate with new investors.
23,507 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
You’ve bought a few rental properties, but the real work starts now. This guide delivers a step-by-step plan to optim...
A new institutional stake in Howard Hughes Holdings suggests rising confidence in the stock. With 140,268 shares boug...
The Supreme Court invalidated President Trump's global tariffs in a 6-3 decision. He vows to impose new duties under ...
A tariff reversal can trigger a short-lived stock market surge, but gains often fade as details unfold. This guide ex...
Meta platforms just gave a crucial signal about AI-driven cloud demand. This piece breaks down why Nebius could stand...
Home Depot posts a solid Q4 with adjusted EPS of $2.72 on revenue of $38.2 billion, beating estimates for the first t...
Nvidia’s latest earnings release produced solid numbers, but traders say the real move will come from the March GTC. ...
NVIDIA's quarterly results come as tech stocks swing, with investors assessing data center demand, margins, and AI ec...
RxSight's Q4 2025 earnings report could set the tone for its 2026 trajectory. This guide breaks down the key numbers,...
As 2025 closes, star bulk (sblk) enters a new chapter. This guide breaks down the Q4 2025 results, fleet strategy, ba...
A sharp rally in Chime Financial shares followed stronger-than-expected Q4 guidance. This piece breaks down the drive...